Metropolitan Life Insurance Company (MetLife)’s Insmed INSM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,265	Closed	-$197K	–	1038
2024 Q1	$197K	Sell	7,265 -593	-8%	-$16.6K	0.01%	725
2023 Q4	$244K	Buy	7,858 +212	+3%	+$5.5K	0.01%	653
2023 Q3	$193K	Buy	7,646 +147	+2%	+$3.36K	0.01%	691
2023 Q2	$158K	Hold	7,499	–	–	0.01%	786
2023 Q1	$128K	Sell	7,499 -855	-10%	-$16.6K	0.01%	877
2022 Q4	$167K	Buy	8,354 +881	+12%	+$17K	0.01%	788
2022 Q3	$161K	Hold	7,473	–	–	0.01%	760
2022 Q2	$147K	Hold	7,473	–	–	0.01%	856
2022 Q1	$176K	Sell	7,473 -22,831	-75%	-$530K	0.01%	887
2021 Q4	$825K	Hold	30,304	–	–	0.01%	1109
2021 Q3	$835K	Buy	30,304 +596	+2%	+$15.6K	0.01%	1100
2021 Q2	$845K	Buy	29,708 +1,862	+7%	+$55.3K	0.01%	1145
2021 Q1	$948K	Sell	27,846 -1,191	-4%	-$45.5K	0.01%	971
2020 Q4	$967K	Hold	29,037	–	–	0.01%	899
2020 Q3	$933K	Sell	29,037 -1,896	-6%	-$54.5K	0.02%	787
2020 Q2	$852K	Buy	30,933 +2,474	+9%	+$58.7K	0.02%	832
2020 Q1	$456K	Buy	28,459 +520	+2%	+$12.3K	0.01%	1094
2019 Q4	$667K	Sell	27,939 -801	-3%	-$16.3K	0.01%	1152
2019 Q3	$507K	Buy	28,740 +3,725	+15%	+$71.9K	0.01%	1287
2019 Q2	$640K	Hold	25,015	–	–	0.01%	1150
2019 Q1	$727K	Sell	25,015 -991	-4%	-$25.7K	0.01%	1069
2018 Q4	$341K	Buy	26,006 +1,075	+4%	+$17.2K	0.01%	1468
2018 Q3	$504K	Hold	24,931	–	–	0.01%	1344
2018 Q2	$590K	Hold	24,931	–	–	0.01%	1200
2018 Q1	$561K	Buy	24,931 +615	+3%	+$16.2K	0.01%	1199
2017 Q4	$758K	Sell	24,316 -24,660	-50%	-$728K	0.01%	1032
2017 Q3	$1.53M	Buy	48,976 +4,839	+11%	+$92.2K	0.01%	1039
2017 Q2	$757K	Hold	44,137	–	–	0.01%	1409
2017 Q1	$773K	Sell	44,137 -985	-2%	-$15.2K	0.01%	1368
2016 Q4	$597K	Buy	45,122 +995	+2%	+$13.6K	﹤0.01%	1620
2016 Q3	$641K	Hold	44,127	–	–	﹤0.01%	1543
2016 Q2	$435K	Hold	44,127	–	–	﹤0.01%	1788
2016 Q1	$559K	Hold	44,127	–	–	﹤0.01%	1515
2015 Q4	$801K	Hold	44,127	–	–	0.01%	1305
2015 Q3	$819K	Sell	44,127 -1,145	-3%	-$28.6K	0.01%	1299
2015 Q2	$1.11M	Buy	45,272 +5,971	+15%	+$136K	0.01%	1223
2015 Q1	$817K	Hold	39,301	–	–	0.01%	1318
2014 Q4	$608K	Hold	39,301	–	–	﹤0.01%	1630
2014 Q3	$513K	Buy	39,301 +10,579	+37%	+$160K	﹤0.01%	1704
2014 Q2	$574K	Hold	28,722	–	–	﹤0.01%	1738
2014 Q1	$547K	Hold	28,722	–	–	﹤0.01%	1754
2013 Q4	$489K	Hold	28,722	–	–	﹤0.01%	1824
2013 Q3	$448K	Buy	28,722 +4,993	+21%	+$63.4K	﹤0.01%	1820
2013 Q2	$284K	Buy	+23,729	New	+$243K	﹤0.01%	2091

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INSM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Insmed (INSM) in Q2 2024, closing a stake of 7,265 shares — an estimated $197K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INSM in Q2 2013 and held it in 44 quarters. The position peaked at $1.53M in Q3 2017. 378 funds tracked by Wall St. Rank hold INSM as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Insmed position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 7,265 Insmed shares in Q2 2024, an estimated $197K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Insmed in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Insmed position peaked at $1.53M in Q3 2017.
378 funds tracked by Wall St. Rank held Insmed as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.